Direct oral anticoagulants and heparins: laboratory values and pitfalls in ‘bridging therapy’

Abstract

Direct thrombin and FXa inhibitors exhibit distinct effects on assay results when used concomitantly with heparins. These interactions must be considered in the interpretation of assay results during bridging therapy.